Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma

BJU International

Volumn 113, Issue 5, 2014, Pages 813-821

  Izquierdo, Laura ^a   Ingelmo Torres, Mercedes ^a   Mallofré, Carmen ^a   Lozano, Juan José ^b   Verhasselt Crinquette, Marie ^c   Leroy, Xavier ^c   Colin, Pierre ^d   Comperat, Eva ^e   Roupret, Morgan ^e   Alcaraz, Antonio ^a   Mengual, Lourdes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIV LILLE   (France)

^d Général de Santé   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

microRNA; prognosis; quantitative PCR; upper tract urothelial carcinoma

Indexed keywords

MICRORNA; MICRORNA 106B; MICRORNA 141; MICRORNA 149; MICRORNA 15A; MICRORNA 17; MICRORNA 181A; MICRORNA 183; MICRORNA 195; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 210; MICRORNA 31; MICRORNA 34A; MICRORNA 378; MICRORNA 487B; MICRORNA 493; MICRORNA 610; MICRORNA 629; MICRORNA 7; MICRORNA 93; MICRORNA 95; MICRORNA 99A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RNA ANALYSIS; TRANSITIONAL CELL CARCINOMA; VALIDATION PROCESS;

MICRORNA; PROGNOSIS; QUANTITATIVE PCR; UPPER TRACT UROTHELIAL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS;

EID: 84898621232     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12551     Document Type: Article

References (29)

1. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
2. Huben RP, Mounzer AM, Murphy GP,. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988; 62: 2016-2020 (Pubitemid 18261830)
3. Roupret M, Hupertan V, Seisen T, et al. Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol 2012; 189: 1662-1669
4. Lin T, Dong W, Huang J, et al. MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 2009; 181: 1372-1380
5. Vogt M, Munding J, Gruner M, et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 2011; 458: 313-322
6. Yamada Y, Enokida H, Kojima S, et al. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 2011; 102: 522-529
7. Catto JW, Miah S, Owen HC, et al. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009; 69: 8472-8481
8. Hui AB, Shi W, Boutros PC, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 2009; 89: 597-606
9. Lopez-Beltran A, Sauter G, Gasser T, et al. World Health Organization. Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004
10. Sobin LH, Wittekind C,. TNM Classification of Malignant Tumours, 6th edn. New York: Wiley, 2002
11. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Clin Biochem 2003; 40: 357-363 (Pubitemid 36819552)
12. Mestdagh P, Van Vlierberghe P, De Weer A, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009; 10: R64
13. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034
14. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG,. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009; 25: 1991-1993
15. Izquierdo L, Truan D, Petit A, Gutierrez R, Mallofre C, Alcaraz A,. Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P/GSK-3beta/beta-catenin pathway. BJU Int 2009; 104: 100-106
16. Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T,. E-cadherin expression in upper-urinary-tract carcinoma. Int J Cancer 1997; 74: 446-449 (Pubitemid 27400167)
17. Nakanishi K, Hiroi S, Tominaga S, et al. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 2005; 11: 2583-2590 (Pubitemid 40569457)
18. Kashibuchi K, Tomita K, Schalken JA, et al. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract. Eur Urol 2006; 49: 839-845
19. Izquierdo L, Truan D, Mengual L, Mallofre C, Alcaraz A,. HER-2/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications. Anticancer Res 2010; 30: 2439-2445
20. Kamai T, Takagi K, Asami H, Ito Y, Arai K, Yoshida KI,. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter. BJU Int 2000; 86: 14-19 (Pubitemid 30420757)
21. Eltz S, Comperat E, Cussenot O, Roupret M,. Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 2008; 102: 532-535
22. Nakanishi K, Kawai T, Hiroi S, et al. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract. Cancer 1999; 86: 2109-2116
23. Mengual L, Burset M, Ars E, et al. Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer. Eur Urol 2006; 50: 1347-1355
24. Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ, Alcaraz A,. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 2013; 113: 2631-2641
25. Wang F, Ma YL, Zhang P, et al. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 2012; 229: 12-24
26. Wang CJ, Stratmann J, Zhou ZG, Sun XF,. Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 2010; 10: 616
27. Christopoulos P, Pfeifer D, Bartholome K, et al. Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL. Blood 2011; 117: 3836-3846
28. Lu L, Luo ST, Shi HS, et al. AAV2-mediated gene transfer of VEGF-Trap with potent suppression of primary breast tumor growth and spontaneous pulmonary metastases by long-term expression. Oncol Rep 2012; 28: 1332-1338
29. Ragan C, Zuker M, Ragan MA,. Quantitative prediction of miRNA-mRNA interaction based on equilibrium concentrations. PLoS Comput Biol 2011; 7: e1001090